Medtronic accurhythm ai technology receives 2023 medtech breakthrough award as best new monitoring solution

Accurhythm ai algorithms now cleared by fda for the reveal linq icm; enhancements made to the af algorithm for the linq ii icm  dublin , may 16, 2023 /prnewswire/ -- medtronic plc (nyse: mdt) today announced its accurhythm™ ai algorithm technology is the winner of the 7th annual medtech breakthrough awards program as the "best new monitoring solution."  accurhythm ai is an artificial intelligence algorithm that improves the accuracy of heart rhythm event data from the medtronic linq ii™ insertable cardiac monitor (icm) so physicians can better care for people with abnormal heart rhythms.
MDT Ratings Summary
MDT Quant Ranking